Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice

Clinical Nutrition

Volumn 29, Issue 5, 2010, Pages 663-673

  Sanchez Fidalgo S ^a   Villegas, I ^a   Cardeno A ^a   Talero, E ^a   Sanchez Hidalgo M ^a   Motilva, V ^a   Alarcon de la Lastra C ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

catenin; Colorectal cancer; Extra virgin olive oil; Inflammation parameters; Ulcerative colitis

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; CYTOKINE; DEXTRAN SULFATE; INDUCIBLE NITRIC OXIDE SYNTHASE; OLIVE OIL; SUNFLOWER OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CELL MEMBRANE; CELL NUCLEUS; COLON CARCINOGENESIS; COLON INJURY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADENOCARCINOMA; ANIMALS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DIET; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; MICE; MICE, INBRED C57BL; PLANT OILS;

EID: 77957350007     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.03.003     Document Type: Article

References (75)

1. Itzkowitz S.H. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2006, 35:553-571.
2. Motilva V., Talero E., Calvo J.R., Villegas I., Alarcón-de-la-Lastra C., Sánchez-Fidalgo S. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities. Curr Pharm Des 2008, 14:71-95.
3. Gavert N., Ben-Ze'ev A. Beta-Catenin signaling in biological control and cancer. J Cell Biochem 2007, 102:820-828.
4. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003, 94:965-973.
5. Müller-Decker K., Fürstenberger G. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis. Mol Carcinog 2007, 46:705-710.
6. Kawanishi S., Hiraku Y., Pinlaor S., Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 2006, 387:365-372.
7. Mutoh M., Takahashi M., Wakabayashi K. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. Curr Pharm Des 2006, 12:2375-2382.
8. Burstein E., Fearon E.R. Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest 2008, 118:464-467.
9. Davidson L.A., Nguyen D.V., Hokanson R.M., Callaway E.S., Isett R.B., Turner N.D., et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004, 64:6797-6804.
10. Owen R.W., Haubner R., Wurtele G., Hull E., Spiegelhalder B., Bartsch H. Olives and olive oil in cancer prevention. Eur J Cancer Prev 2004, 13:319-326.
11. Cottet V., Bonithon-Kopp C., Kronborg O., Santos L., Andreatta R., Boutron-Ruault M.C., et al. Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev 2005, 14:21-29. European Cancer Prevention Organisation Study Group.
12. Alarcón de la Lastra C., Barranco M.D., Motilva V., Herrerias J.M. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001, 7:933-950.
13. Fujise T., Iwakiri R., Kakimoto T., Shiraishi R., Sakata Y., Wu B., et al. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1150-G1156.
14. Bartoli R., Fernandez-Banares F., Navarro E., Castella E., Mane J., Alvarez M., et al. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin (E2) synthesis. Gut 2000, 46:191-199.
15. Onogi N., Okuno M., Komaki C., Moriwaki H., Kawamori T., Tanaka T., et al. Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats. Carcinogenesis 1996, 17:1291-1296.
16. Hashim Y.Z., Rowland I.R., McGlynn H., Servili M., Selvaggini R., Taticchi A., et al. Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro. Int J Cancer 2008, 122:495-500.
17. Gill C.I., Boyd A., McDermott E., McCann M., Servili M., Selvaggini R., et al. Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro. Int J Cancer 2005, 117:1-7.
18. Carrier J.C., Aghdassi E., Jeejeebhoy K., Allard J.P. Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB. Int J Colorectal Dis 2006, 21:81-387.
19. Erichsen K., Milde A.M., Arslan G., Helgeland L., Gudbrandsen O.A., Ulvik R.J., et al. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005, 11:744-748.
20. Seril D.N., Liao J., Yang C.S., Yang G.Y. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Dig Dis Sci 2005, 50:696-707.
21. Yeo M., Kim D.K., Park H.J., Oh T.Y., Kim J.H., Cho S.W., et al. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics 2006, 6:1158-1165.
22. Gommeaux J., Cano C., Garcia S., Gironella M., Pietri S., Culcasi M., et al. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 2007, 27:2215-2228.
23. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
24. Osawa E., Nakajima A., Fujisawa T., et al. Predominant T helper type 2-inflammatory responses promote murine colon cancers. Int J Cancer 2006, 118:2232-2236.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
26. Kohno H., Suzuki R., Sugie S., Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 2005, 5:46.
27. Woutersen R.A., Appel M.J., Garderen-Hoetmer A., Wijnands M. Dietary fat and carcinogenesis. Mutat Res 1999, 443:111-127.
28. Reddy B.S. Nutritional factors and colon cancer. Crit Rev Food Sci Nutr 1995, 35:175-190.
29. Rao C.V., Hirose Y., Indranie C., Reddy B.S. Moduration of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001, 61:1927-1933.
30. Lipworth L., Martinez M.E., Angell J., Hsieh C.C., Trichopoulos D. Olive oil and human cancer: an assessment of the evidence. Prev Med 1997, 26:181-190.
31. Escrich E., Moral R., Grau L., Costa I., Solanas M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res 2007, 51:1279-1292.
32. Schwartz B., Birk Y., Raz A., Madar Z. Nutritional-pharmacological combinations: a novel approach to reducing colon cancer incidence. Eur J Nutr 2004, 43:221-229.
33. Femia A., Dolara P., Servili M., Esposto S., Taticchi A., Urbani S., et al. No effects of olive oils with different phenolic content compared to corn oil on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Eur J Nutr 2008, 47:329-334.
34. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnandath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., Thibodeau S.N. Mutations in Axin2 cause colorectal cancer with detective mismatch repair by activating beta-c-atenin-Tcf signaling. Nat Genet 2000, 26:146-147.
35. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutation in beta catenin or APC. Science 1997, 275:1787-1790.
36. von Kries J.P., Winbeck G., Asbrand C., Schwarz-Romond T., Sochnikowa N., Dell'Oro A., Behrens J., Birchmeier W. Hot spots in betacatenin for interactions with LEF-1, conduction and APC. Nat Struct Biol 2000, 7:800-807.
37. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.
38. Fujii S., Fujimori T., Kawamata H., Takada J., Kitajima K., Omotehara F., Kaihara T., Kusaka T., Ichikawa K., Ohkura Y., Ono Y., Imura J., Yamaoka S., Sakamoto C., Ueda Y., Chiba T. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004, 53:710-716.
39. Furihata T., Kawamata H., Kubota K., Fujimori T. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for betacatenin in inflammation-induced rat colon carcinogenesis. Int J Mol Med 2002, 9:353-358.
40. Aust D.E., Terdiman J.P., Willenbucher R.F., Chew K., Ferrell L., Florendo C., Molinaro-Clark A., Baretton G.B., Löhrs U., Waldman F.M. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Mod Pathol 2001, 14:29-39.
41. Babbar N., Casero R.A. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 2006, 66:11,125-11,130.
42. Scott K.A., Moore R.J., Arnott C.H., East N., Thompson R.G., Scallon B.J., Shealy D.J., Balkwill F.R. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol Cancer Ther 2003, 2:445-451.
43. Popivanova B.K., Kitamura K., Wu Y., Kondo T., Kagaya T., Kaneko S., et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008, 118:560-570.
44. Erdman S.E., Rao V.P., Poutahidis T., Rogers A.B., Taylor C.L., Jackson E.A., Ge Z., Lee C.W., Schauer D.B., Wogan G.N., Tannenbaum S.R., Fox J.G. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci USA 2009, 106:1027-1032.
45. Bromberg J., Wang T.C. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009, 15:79-80.
46. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118:285-296.
47. Grivennikov S., Karin E., Terzic J., Mucida D., Yu G.Y., Vallabhapurapu S., et al. IL-6 and stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009, 15:103-113.
48. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124.
49. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
50. Itzkowitz S.H., Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004, 287:G7-G17.
51. Narayanan B.A., Narayanan N.K., Simi B., Reddy B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res 2003, 63:972-979.
52. Elder D.J., Baker J.A., Banu N.A., Moorghen M., Paraskeva C. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol 2002, 198:428-434.
53. Rao C.V., Indranie C., Simi B., Manning P.T., Connor J.R., Reddy B.S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002, 62:165-170.
54. Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., Kaidi A. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumor microenvironment. Carcinogenesis 2009, 30:377-386.
55. Samanta S., Swamy V., Suresh D., Rajkumar M., Rana B., Rana A., et al. Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O6-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction. Mutat Res 2008, 650:123-131.
56. Dempke W., Rie C., Grothey A., Schmoll H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy?. J Cancer Res Clin Oncol 2001, 127:411-417.
57. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001, 2:149-156.
58. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18:7908-7916.
59. Battu S., Rigaud M., Beneytout J.L. Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL.19A. Anticancer Res 1998, 18:3579-3583.
60. Steele V.E., Hawk E.T., Viner J.L., Lubet R.A. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res 2003, 523-524:137-144.
61. Dannenberg A.J., Zakim D. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol 1999, 26:499-504.
62. Felley-Bosco E. Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev 1998, 17:25-37.
63. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995, 92:4392-4396.
64. Narayanan B.A., Narayanan N.K., Reddy B.S. Docosahexaenoic acid (DHA) regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 2001, 19:1255-1262.
65. Barlev N.A., Liu L., Chehab N.H., Mansfield K., Harris K.G., Halazonetis T.D., et al. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 2001, 8:243-254.
66. Espinosa J.M., Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001, 8:57-69.
67. Liu L., Scolnick D., Trievel R.C., Zhang H.B., Marmorstein R., Halazonetis T.D., et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 1999, 19:1202-1209.
68. Sakaguchi K., Herrera J.E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C.W., Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998, 12:2831-2841.
69. Gu W., Roeder R. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90:595-606.
70. Takenaka I., Morin F.F., Seizinger B.R., Kley N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 1995, 270:5405-5411.
71. Hupp T.R., Lane D.P. Allosteric activation of latent p53 tetramers. Curr Biol 1994, 4:865-875.
72. Xie J., Itzkowitz S.H. Cancer in inflammatory bowel disease. World J Gastroenterol 2008, 14:378-389.
73. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
74. Wang J.G., Wang D.F., Lv B.J., Si J.M. A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2 dimethylhydrazine and dextran sulfate sodium. World J Gastroenterol 2004, 10:2958-2962.
75. Cooper H.S., Murthy S., Kido K., Yoshitake H., Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000, 21:757-768.